Ningxia Zhongke Biotechnology Co (SHSE:600165) Change In Inventory: ¥0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
47 GF Score
Price ¥3.25
GF Value ¥2.34
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co Change In Inventory?

Ningxia Zhongke Biotechnology Co SHSE:600165 -0.61% 47 Change In Inventory is ¥0.0 Mil as of Jun. 2026. GuruFocus rates SHSE:600165 with a GF Score™ of 47/100 and a GF Value™ of ¥2.34 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Ningxia Zhongke Biotechnology Co's change in inventory for the quarter that ended in Jun. 2026 was ¥0.0 Mil. It means Ningxia Zhongke Biotechnology Co's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Ningxia Zhongke Biotechnology Co's change in inventory for the fiscal year that ended in Dec. 2025 was ¥-50.3 Mil. It means Ningxia Zhongke Biotechnology Co's inventory increased by ¥50.3 Mil from Dec. 2024 to Dec. 2025 .

Ningxia Zhongke Biotechnology Co's Total Inventories for the quarter that ended in Jun. 2026 was ¥177.5 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ningxia Zhongke Biotechnology Co's Days Inventory for the quarter that ended in Jun. 2026 was 87.69.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ningxia Zhongke Biotechnology Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ningxia Zhongke Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.12.


Ningxia Zhongke Biotechnology Co  (SHSE:600165) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ningxia Zhongke Biotechnology Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=175.261/182.377*365 / 4
=87.69

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ningxia Zhongke Biotechnology Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ningxia Zhongke Biotechnology Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ningxia Zhongke Biotechnology Co Change In Inventory Related Terms


Ningxia Zhongke Biotechnology Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Ningxia Zhongke Biotechnology Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningxia Zhongke Biotechnology Co Change In Inventory Chart

Ningxia Zhongke Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -121.37 59.42 35.33 -1.70 -50.31

Ningxia Zhongke Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:600165
47GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningxia Zhongke Biotechnology Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ¥0.0 Mil mean?
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a Change In Inventory of ¥0.0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Ningxia Zhongke Biotechnology Co and its competitors.
Is Ningxia Zhongke Biotechnology Co's Change In Inventory too high?
Ningxia Zhongke Biotechnology Co's current Change In Inventory is ¥0.0 Mil. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's Change In Inventory compare to LIN and SHW?
Ningxia Zhongke Biotechnology Co's Change In Inventory of ¥0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Chemicals company?
A good Change In Inventory depends on the Chemicals industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Ningxia Zhongke Biotechnology Co and its competitors. Ningxia Zhongke Biotechnology Co's current Change In Inventory is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.34, compared to a current price of ¥3.25 — trading 38.9% above its estimated fair value. The current Change In Inventory is ¥0.0 Mil. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current Change In Inventory is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be overvalued. The current stock price of ¥3.25 is trading 38.9% above its estimated GF Value™ of ¥2.34. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600165:

  • Change In Inventory: ¥0.0 Mil
  • GF Value™: ¥2.34 vs. price of ¥3.25 (38.9% above fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
47GF Score

Get the complete analysis for SHSE:600165

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.25
Price
¥2.34
GF Value